Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003157 | Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach | completed | Phase 1 | 26 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT02352571 | Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer | unknown | Phase 1 | 72 | Green Cross CorporationINDUSTRY | 1 | Jul 6, 2016 | clinicaltrials |
| NCT01227772 | Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 23 | National University Hospital, SingaporeOTHER | 3 | Jun 22, 2016 | clinicaltrials |
| NCT02030561 | NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer | unknown | Phase 1 / Phase 2 | 29 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02805829 | Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer | unknown | Phase 1 / Phase 2 | 20 | Xuzhou Medical UniversityOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00524186 | Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | terminated | Phase 1 | 23 | Roswell Park Cancer InstituteOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01542294 | SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer | unknown | Phase 1 / Phase 2 | 71 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT02317471 | Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 45 | Chinese PLA General HospitalOTHER | 1 | Jun 6, 2016 | clinicaltrials |
| NCT02252913 | A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer | completed | Phase 1 | 25 | Hutchison Medipharma LimitedINDUSTRY | 1 | Apr 8, 2016 | clinicaltrials |
| NCT02720926 | Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer | terminated | Phase 1 | 3 | National Cancer Centre, SingaporeOTHER | 1 | Mar 28, 2016 | clinicaltrials |
| NCT01637805 | Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer(AAV-DC-CTL) | unknown | Phase 1 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 8, 2016 | clinicaltrials |
| NCT02496273 | Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer | active not recruiting | Phase 1 | 60 | The First People's Hospital of ChangzhouOTHER | 0 | Feb 22, 2016 | clinicaltrials |
| NCT00130936 | Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates | terminated | Phase 1 / Phase 2 | 50 | AHS Cancer Control AlbertaOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT02662348 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | unknown | Phase 1 | 6 | Yi MiaoOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT02283359 | Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus | terminated | Phase 1 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT02632201 | Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis | unknown | Phase 1 / Phase 2 | 40 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT01099527 | A Trial of RAD001/Capecitabine in Refractory Gastric Cancer | completed | Phase 1 / Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01172028 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | University of ArizonaOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT02347956 | The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer | completed | Phase 1 / Phase 2 | 19 | Yonsei UniversityOTHER | 1 | Nov 16, 2015 | clinicaltrials |
| NCT01716546 | Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer | terminated | Phase 1 / Phase 2 | 51 | Hellenic Oncology Research GroupOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01466569 | An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | AbGenomics B.V Taiwan BranchINDUSTRY | 2 | Jun 23, 2015 | clinicaltrials |
| NCT00544193 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | completed | Phase 1 | 16 | City of Hope Medical CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
| NCT01136031 | Paclitaxel and Irinotecan in Advanced Gastric Cancer(TI-2ndAGC) | completed | Phase 1 / Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 19 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00553696 | Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer | completed | Phase 1 | 27 | PfizerINDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT00023634 | S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer | terminated | Phase 1 | 14 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 6, 2015 | clinicaltrials |
| NCT02378389 | Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer | unknown | Phase 1 | 28 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 4, 2015 | clinicaltrials |
| NCT00539968 | A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) | terminated | Phase 1 / Phase 2 | 5 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 5, 2015 | clinicaltrials |
| NCT00511576 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | terminated | Phase 1 | 54 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT00374985 | Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction | completed | Phase 1 / Phase 2 | 25 | Johannes Gutenberg University MainzOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01497964 | Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy(GASTANA) | completed | Phase 1 / Phase 2 | 16 | SanofiINDUSTRY | 1 | Nov 10, 2014 | clinicaltrials |
| NCT00027534 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 14 | Michael Morse, MDOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT02205463 | KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer | withdrawn | Phase 1 | 0 | NYU Langone HealthOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00183846 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | completed | Phase 1 | 22 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183859 | Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan | completed | Phase 1 | 42 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | completed | Phase 1 / Phase 2 | 86 | Chinese PLA General HospitalOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00113581 | Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer | completed | Phase 1 | 26 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01428141 | A Phase I Study of E7050 in Subjects With Solid Tumors | completed | Phase 1 | 18 | Eisai Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00165594 | A Study of E7070 in Patients With Gastric Cancer | terminated | Phase 1 / Phase 2 | 50 | Eisai Co., Ltd.INDUSTRY | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00010270 | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | unknown | Phase 1 | 50 | University Hospital FreiburgOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00072332 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00719550 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | completed | Phase 1 / Phase 2 | 130 | AmgenINDUSTRY | 0 | Dec 5, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 14, 2016source: clinicaltrials